SANXING(SH:601567)2026-03-06 02:20Summary of Conference Call Notes Company and Industry Involved - The company discussed is Samsung Medical, specifically its subsidiary Samsung Sweden which has secured contracts for transformer manufacturing. - The industry focus is on transformer manufacturing and power distribution technology. Core Points and Arguments - Samsung Sweden has signed a framework contract with Enexis in the Netherlands for oil-immersed transformers, amounting to €117 million, approximately ¥949 million [1] - Winning the Dutch contract indicates that Samsung's transformer manufacturing capabilities have met global high-level certifications, particularly due to stringent EU standards on environmental protection, energy efficiency, and noise reduction [1] - The company’s distribution technology is beginning to lead in overseas markets, surpassing many domestic competitors [1] Additional Important Content - The company has progressively secured contracts, starting with a ¥341 million order for oil-immersed transformers in Brazil in 2023, followed by a ¥466 million contract with the Greek power authority (HEDNO) in April 2024, culminating in the recent Dutch order [2] - This sequence of contracts signifies that the company's technological strength is gaining global recognition, moving from simpler to more complex projects [2] - Market perception is shifting positively towards Siyuan Electric in the mid-to-high voltage overseas market, suggesting that Samsung could become a comparable player in the international distribution system [2] - Profit forecasts for 2026 are projected at ¥2.3-2.4 billion, with a current price-to-earnings ratio of 16x, while Siyuan is expected to have a 45x ratio, indicating that Samsung is significantly undervalued and warrants continued attention [2]